The European launch of new diabetes drug Galvus could be delayed by up to six months after small but significant …
The Conservative party says the NHS must be freed from 'political tinkering' in order for it to focus on improving …
The role of pharmacists as frontline NHS clinicians is being promoted by the work of a key committee. The government …
A key target to cut waiting times for operations looks unlikely to be hit by the NHS, prompting the government …
AstraZeneca could face a major blow to its revenues if a generic challenger to Crestor is launched. The cholesterol lowering …
Efforts to cut unnecessary delays to UK clinical trials have taken a step forward with a new agreement to help …
Sanofi-Aventis outperformed expectations in the third quarter, after a strong performance from its vaccines business and the recovery of blockbuster …
NICE has rejected Orenica, a new treatment for rheumatoid arthritis, saying the drug is not a cost effective option for …
Third quarter figures show Roche's top-selling products have all posted double-digit advances on the same period in 2006. Growth for …
News that the health service is to get a new watchdog with increased powers has been criticised by the BMA, …
From the amount of lip service the pharma industry pays to marketing effectiveness, you might be excused for thinking it …
Oxford BioMedica wins key ruling in patent disputeOxford BioMedica has received a favorable ruling in a US district court for …
New measures to help the NHS use resources and technology more effectively have been unveiled by the government, spearheaded by …
GlaxoSmithKline saw sales in its pharmaceutical division dip 2% in the third quarter, as falling demand for Avandia continued to …
AstraZeneca has launched a new website to support patients suffering from mental health conditions who want to change their drug …
The health service is no longer running at a deficit, but new figures show that one third of PCTs and …